Versican and Versican-matrikines in Cancer Progression, Inflammation, and Immunity.

biomarkers dendritic cells extracellular matrix glycosaminoglycan immunotherapy macrophages matrikines myeloid cells proteoglycan versican versikine

Journal

The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society
ISSN: 1551-5044
Titre abrégé: J Histochem Cytochem
Pays: United States
ID NLM: 9815334

Informations de publication

Date de publication:
12 2020
Historique:
pubmed: 7 7 2020
medline: 20 1 2021
entrez: 7 7 2020
Statut: ppublish

Résumé

Versican is an extracellular matrix proteoglycan with key roles in multiple facets of cancer development, ranging from proliferative signaling, evasion of growth-suppressor pathways, regulation of cell death, promotion of neoangiogenesis, and tissue invasion and metastasis. Multiple lines of evidence implicate versican and its bioactive proteolytic fragments (matrikines) in the regulation of cancer inflammation and antitumor immune responses. The understanding of the dynamics of versican deposition/accumulation and its proteolytic turnover holds potential for the development of novel immune biomarkers as well as approaches to reset the immune thermostat of tumors, thus promoting efficacy of modern immunotherapies. This article summarizes work from several laboratories, including ours, on the role of this central matrix proteoglycan in tumor progression as well as tumor-immune cell cross-talk.

Identifiants

pubmed: 32623942
doi: 10.1369/0022155420937098
pmc: PMC7711242
doi:

Substances chimiques

Extracellular Matrix Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

871-885

Subventions

Organisme : NCI NIH HHS
ID : R01 CA252937
Pays : United States

Références

Dev Immunol. 2000;7(2-4):227-38
pubmed: 11097214
J Biol Chem. 2017 Jan 6;292(1):51-63
pubmed: 27895126
Cell Mol Life Sci. 2017 Mar;74(5):761-776
pubmed: 27491428
Matrix Biol. 2014 Apr;35:162-73
pubmed: 24727035
J Neuropathol Exp Neurol. 1996 May;55(5):528-33
pubmed: 8627343
Cell. 2017 Feb 9;168(4):707-723
pubmed: 28187290
Cancer Cell. 2017 May 8;31(5):711-723.e4
pubmed: 28486109
PLoS One. 2010 Nov 05;5(11):e13828
pubmed: 21079779
Am J Respir Crit Care Med. 1999 Aug;160(2):725-9
pubmed: 10430752
Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10116-21
pubmed: 9294172
Leukemia. 2015 Oct;29(10):2024-32
pubmed: 25915825
Cell Res. 2005 Jul;15(7):483-94
pubmed: 16045811
Breast Cancer Res. 2007;9(4):R47
pubmed: 17662123
Matrix Biol. 2014 Apr;35:34-41
pubmed: 24444773
Nat Rev Cancer. 2002 Apr;2(4):277-88
pubmed: 12001989
Annu Rev Immunol. 2013;31:563-604
pubmed: 23516985
JCI Insight. 2018 Mar 8;3(5):
pubmed: 29515038
Anat Embryol (Berl). 1993 Nov;188(5):419-33
pubmed: 7508695
Lab Invest. 2006 Sep;86(9):889-901
pubmed: 16847433
Leuk Lymphoma. 2019 Oct;60(10):2558-2562
pubmed: 30845856
Int J Cancer. 2010 Feb 1;126(3):640-50
pubmed: 19662655
Arch Biochem Biophys. 1997 Mar 15;339(2):353-61
pubmed: 9056268
J Cell Sci. 2006 Nov 1;119(Pt 21):4499-509
pubmed: 17046999
Biochim Biophys Acta. 2012 Jul;1820(7):1009-19
pubmed: 22542782
Anat Rec (Hoboken). 2010 Jun;293(6):968-81
pubmed: 20503391
Hepatology. 2014 Mar;59(3):958-73
pubmed: 24005989
Int J Cancer. 2005 May 10;114(6):879-86
pubmed: 15645431
Cardiovasc Res. 2010 May 1;86(2):226-35
pubmed: 20154066
Oncogenesis. 2016 Dec 12;5(12):e277
pubmed: 27941932
J Histochem Cytochem. 2011 May;59(5):463-73
pubmed: 21411713
Clin Cancer Res. 2003 Sep 15;9(11):4190-9
pubmed: 14519645
Mol Med Rep. 2016 Jun;13(6):5005-12
pubmed: 27109786
J Biol Chem. 1998 Aug 14;273(33):21342-51
pubmed: 9694895
Adv Immunol. 2013;120:239-67
pubmed: 24070387
Dev Biol. 1998 Oct 1;202(1):56-66
pubmed: 9758703
Arterioscler Thromb Vasc Biol. 1999 Apr;19(4):1004-13
pubmed: 10195929
Glycobiology. 2015 Mar;25(3):243-51
pubmed: 25371494
Blood. 2016 Aug 4;128(5):680-5
pubmed: 27259980
J Clin Pathol. 2004 Jul;57(7):735-9
pubmed: 15220367
Oncoimmunology. 2012 Sep 1;1(6):798-809
pubmed: 23162747
Crit Care. 2011;15(1):R4
pubmed: 21211006
Matrix Biol. 2017 Jul;60-61:38-56
pubmed: 27932299
Crit Rev Oncol Hematol. 2004 Mar;49(3):199-202
pubmed: 15036260
Clin Cancer Res. 1998 Apr;4(4):963-71
pubmed: 9563891
Cell Rep. 2015 Dec 29;13(12):2851-64
pubmed: 26711349
Annu Rev Biochem. 1998;67:609-52
pubmed: 9759499
Nature. 2009 Jan 1;457(7225):102-6
pubmed: 19122641
Breast Cancer. 2012 Jan;19(1):46-53
pubmed: 21505857
J Cell Biochem. 1999 Feb 1;72(2):210-20
pubmed: 10022503
Cancer Res. 2013 Aug 15;73(16):5016-28
pubmed: 23824740
FEBS Lett. 2013 Jan 16;587(2):185-92
pubmed: 23201264
JCI Insight. 2019 Apr 23;5:
pubmed: 31013254
FASEB J. 2004 Apr;18(6):754-6
pubmed: 14766798
Blood. 2014 May 22;123(21):3305-15
pubmed: 24723682
Matrix Biol. 2005 Feb;24(1):3-13
pubmed: 15748997
Nat Rev Mol Cell Biol. 2014 Dec;15(12):786-801
pubmed: 25415508
Mod Pathol. 2010 Dec;23(12):1605-15
pubmed: 20729814
Sci Rep. 2017 Dec 8;7(1):17225
pubmed: 29222454
J Biol Chem. 2014 Dec 5;289(49):34089-103
pubmed: 25320080
J Neuropathol Exp Neurol. 1999 Jun;58(6):597-605
pubmed: 10374750
Int Immunol. 1999 Mar;11(3):393-405
pubmed: 10221651
J Cell Sci. 2004 Nov 15;117(Pt 24):5887-95
pubmed: 15522894
Am J Pathol. 2007 Mar;170(3):1086-99
pubmed: 17322391
Front Immunol. 2019 Apr 24;10:875
pubmed: 31068944
Am J Physiol Lung Cell Mol Physiol. 2017 Dec 1;313(6):L1069-L1086
pubmed: 28912382
J Immunol. 2006 Nov 15;177(10):7303-11
pubmed: 17082649
J Immunother Cancer. 2018 Jul 3;6(1):65
pubmed: 29970158
Int J Mol Sci. 2011 Jan 31;12(2):1009-29
pubmed: 21541039
PLoS One. 2013;8(2):e56616
pubmed: 23424670
Cancer Res. 2001 Feb 1;61(3):926-30
pubmed: 11221884
J Clin Pathol. 2016 Oct;69(10):906-11
pubmed: 26951084
J Biol Chem. 2002 Feb 8;277(6):4565-72
pubmed: 11726670
Am J Respir Cell Mol Biol. 2010 Jul;43(1):109-20
pubmed: 19717812
Mol Cancer Res. 2013 May;11(5):443-55
pubmed: 23449934
J Immunol. 2017 Sep 1;199(5):1933-1941
pubmed: 28754680
Am J Pathol. 2002 Feb;160(2):549-57
pubmed: 11839575
Oncotarget. 2015 Dec 22;6(41):43529-39
pubmed: 26527314
J Biol Chem. 1986 Oct 15;261(29):13526-35
pubmed: 3759976
Nat Immunol. 2015 Jul;16(7):708-17
pubmed: 26054719
FEBS J. 2013 Jun;280(12):2870-87
pubmed: 23601700
Neuro Oncol. 2015 Feb;17(2):200-10
pubmed: 25452390
J Biol Chem. 2000 Nov 10;275(45):35448-56
pubmed: 10950950
J Clin Pathol. 2007 Mar;60(3):267-72
pubmed: 16731595
Int J Mol Sci. 2012;13(6):6873-82
pubmed: 22837669
Blood. 2020 Jul 08;:
pubmed: 32640012
Lab Invest. 1995 Aug;73(2):157-60
pubmed: 7637316
Matrix Biol. 2018 Oct;71-72:396-420
pubmed: 29499356
Arch Biochem Biophys. 2001 Oct 1;394(1):29-38
pubmed: 11566024
Oncoimmunology. 2012 Oct 1;1(7):1175-1177
pubmed: 23170270
PLoS One. 2011;6(11):e26396
pubmed: 22096483
Curr Opin Cell Biol. 2002 Oct;14(5):617-23
pubmed: 12231358
Cancer Cell. 2004 Sep;6(3):297-305
pubmed: 15380520
Semin Oncol. 2015 Aug;42(4):663-71
pubmed: 26320069
Biochim Biophys Acta. 2014 Aug;1840(8):2441-51
pubmed: 24401530
Glycobiology. 2020 May 19;30(6):365-373
pubmed: 31651027
Arch Med Res. 2009 May;40(4):321-3
pubmed: 19608024
Matrix Biol. 2020 May;87:77-93
pubmed: 31669737
Matrix Biol. 2014 Apr;35:152-61
pubmed: 24513039
Int J Cancer. 2016 Feb 1;138(3):630-41
pubmed: 26270355
PLoS Biol. 2016 Nov 17;14(11):e1002580
pubmed: 27855162
Int J Cancer. 2012 May 15;130(10):2271-81
pubmed: 21671478
Nat Rev Immunol. 2010 Oct;10(10):712-23
pubmed: 20865019
Arthritis Res Ther. 2013 Jul 11;15(4):R74
pubmed: 23845159
J Leukoc Biol. 2000 Feb;67(2):149-59
pubmed: 10670574
Biochem J. 2004 Feb 1;377(Pt 3):787-95
pubmed: 14561220
Cancer Res. 2007 May 15;67(10):4742-50
pubmed: 17510402
Immunity. 2014 Jul 17;41(1):49-61
pubmed: 25035953
Am J Respir Crit Care Med. 1996 Dec;154(6 Pt 1):1819-28
pubmed: 8970376
Cancer Res. 2012 Oct 1;72(19):4883-9
pubmed: 23002209
Eur Respir J. 2008 Jul;32(1):61-9
pubmed: 18321931
Clin Cancer Res. 2002 Apr;8(4):1054-60
pubmed: 11948113
J Biol Chem. 2001 Jan 12;276(2):1253-61
pubmed: 11038354
Front Endocrinol (Lausanne). 2018 Mar 06;9:69
pubmed: 29559954
J Biol Chem. 2007 Apr 6;282(14):10814-25
pubmed: 17293599
Cancer Res. 2012 Mar 15;72(6):1384-94
pubmed: 22282653
Int J Biochem Cell Biol. 2008;40(6-7):1101-10
pubmed: 18243041
J Clin Endocrinol Metab. 2017 May 1;102(5):1631-1641
pubmed: 28323982
Matrix Biol. 2012 Mar;31(2):90-100
pubmed: 22155153
Neuroscience. 2009 Mar 17;159(2):780-6
pubmed: 19167466
J Cell Biochem. 1999 Jun 15;73(4):445-57
pubmed: 10733339
Front Immunol. 2018 Dec 20;9:3059
pubmed: 30619378
Ann Oncol. 2007 Feb;18(2):269-74
pubmed: 17065588
Cancer Res. 2003 Aug 15;63(16):4786-91
pubmed: 12941795
Cell Tissue Res. 2015 Sep;361(3):833-44
pubmed: 25715761
J Biol Chem. 2005 Sep 2;280(35):30899-908
pubmed: 16006654
Front Oncol. 2019 Jul 03;9:577
pubmed: 31334111
Oncoimmunology. 2018 Nov 2;8(2):e1537427
pubmed: 30713792

Auteurs

Athanasios Papadas (A)

Division of Blood and Marrow Transplantation, Department of Medicine, Moores Cancer Center, University of California, San Diego, La Jolla, CA.
Cellular & Molecular Pathology Graduate Program, University of Wisconsin-Madison, Madison, WI.

Garrett Arauz (G)

Division of Blood and Marrow Transplantation, Department of Medicine, Moores Cancer Center, University of California, San Diego, La Jolla, CA.

Alexander Cicala (A)

Division of Blood and Marrow Transplantation, Department of Medicine, Moores Cancer Center, University of California, San Diego, La Jolla, CA.

Joshua Wiesner (J)

Division of Blood and Marrow Transplantation, Department of Medicine, Moores Cancer Center, University of California, San Diego, La Jolla, CA.

Fotis Asimakopoulos (F)

Division of Blood and Marrow Transplantation, Department of Medicine, Moores Cancer Center, University of California, San Diego, La Jolla, CA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH